GH - Guardant Health - Stock Price & Dividends

Guardant Health Inc is a pioneering precision oncology company that has revolutionized the field of cancer diagnosis and treatment. By leveraging cutting-edge technology, the company provides a comprehensive range of blood and tissue tests, data sets, and analytics to healthcare professionals and researchers globally.

Their innovative product portfolio includes Guardant360, a liquid biopsy test that detects cancer biomarkers in blood samples, as well as Guardant360 LDT, CDx Test, Response Test, and TissueNext Test, which cater to specific clinical and research needs. Additionally, GuardantINFINITY Test and GuardantOMNI Test are designed for advanced stage cancer patients, while GuardantINFORM is an in-silico research platform that enables researchers to study tumor evolution and treatment resistance.

Guardant Health's suite of solutions also includes GuardantConnect, an integrated software platform that connects patients with actionable alterations to relevant clinical studies. This platform facilitates collaboration between clinicians, researchers, and biopharmaceutical companies, ultimately accelerating the development of new cancer therapies.

The company's commitment to innovation is further demonstrated by its development of the Shield Test, Guardant Reveal Test, Smart Liquid Biopsy Platform, and Guardant Galaxy, an AI-backed digital pathology platform that enhances cancer biomarker detection. These cutting-edge technologies have the potential to transform the landscape of cancer diagnosis and treatment.

Guardant Health's collaborative approach is evident in its partnership with Illumina, Inc., which enables the sharing of specimen samples to advance cancer research. The company's development services, including companion diagnostic development, clinical study setup, and technology licensing, further underscore its dedication to driving progress in the field of oncology.

Founded in 2011 and headquartered in Palo Alto, California, Guardant Health Inc is a trailblazer in the precision oncology space, with a strong online presence at https://guardanthealth.com.